Therefore, our next goal was to investigate whether silencing the NCAPH gene could enhance the sensitivity of PCa cells to PI3K/AKT/mTOR or cyclin-dependent kinase (CDK) inhibitors. This evidence concerns the gene NCAPH and posterior cortical atrophy.